Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)

BIOLOGICAL2 trials

Sponsors

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Conditions

Tuberculosis

Phase 1

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

CompletedNCT04239313

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Tuberculosis

Start: 2020-05-27End: 2022-06-20Updated: 2022-09-06

Phase 2

A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

SuspendedNCT05284812

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Tuberculosis

Start: 2022-02-10End: 2024-12-31Target: 200Updated: 2023-11-28

Related Papers

Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus

Vaccines2022-12-1510 citations